THE LIVINGSTON GROUP, LLC

Lobbying for INNOVATIVE VACCINE TECHNOLOGIES · Bio tech company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Utah · $30,000.00 income · posted Apr 10, 2025

Lobbying activity 2

Medical/Disease Research/Clinical Labs

FY2026 appropriations for the development of a synthetic vaccine

Budget/Appropriations

FY2026 appropriations for the development of a synthetic vaccine

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.